Horan Securities, Inc. Amarin Corp Plcuk Transaction History

Horan Securities, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 18, 2023	BUY	$1.19 - $2.19 $2,136 - $3,931	1,795 Added 384.37%	2,262 $3,000
Q4 2022 Jan 17, 2023	SELL	$1.07 - $1.34 $2,711 - $3,395	-2,534 Reduced 84.44%	467 $0
Q2 2022 Jul 19, 2022	BUY	$1.13 - $3.69 $1,281 - $4,184	1,134 Added 60.74%	3,001 $4,000
Q1 2022 May 10, 2022	BUY	$2.85 - $3.73 $760 - $995	267 Added 16.69%	1,867 $6,000
Q4 2021 Feb 09, 2022	BUY	$3.24 - $5.18 $5,184 - $8,288	1,600 New	1,600 $5,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $202M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Horan Securities, Inc., based on Form 13F filings with the SEC.

Stay updated on Horan Securities, Inc. with notifications on news.